Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 30, 2020

SELL
$31.75 - $37.25 $4.18 Million - $4.9 Million
-131,595 Closed
0 $0
Q2 2020

Jul 30, 2020

SELL
$30.12 - $36.54 $39.4 Million - $47.8 Million
-1,307,920 Reduced 90.86%
131,595 $4.3 Million
Q1 2020

Apr 27, 2020

BUY
$27.03 - $38.62 $93,550 - $133,663
3,461 Added 0.24%
1,439,515 $47 Million
Q4 2019

Jan 29, 2020

SELL
$32.92 - $37.36 $5.43 Million - $6.16 Million
-165,012 Reduced 10.31%
1,436,054 $56.3 Million
Q3 2019

Oct 29, 2019

SELL
$32.49 - $42.13 $836,487 - $1.08 Million
-25,746 Reduced 1.58%
1,601,066 $57.5 Million
Q2 2019

Jul 19, 2019

SELL
$36.98 - $41.52 $487,729 - $547,607
-13,189 Reduced 0.8%
1,626,812 $70.5 Million
Q1 2019

Apr 26, 2019

SELL
$37.5 - $41.2 $13.4 Million - $14.7 Million
-357,953 Reduced 17.92%
1,640,001 $69.7 Million
Q4 2018

Jan 11, 2019

SELL
$38.47 - $43.86 $1.58 Million - $1.8 Million
-41,134 Reduced 2.02%
1,997,954 $87.2 Million
Q3 2018

Oct 19, 2018

SELL
$34.47 - $41.81 $130,296 - $158,041
-3,780 Reduced 0.19%
2,039,088 $89.9 Million
Q2 2018

Jul 17, 2018

SELL
$32.98 - $35.16 $2.09 Million - $2.23 Million
-63,384 Reduced 3.01%
2,042,868 $74.1 Million
Q1 2018

Apr 04, 2018

BUY
$31.91 - $37.02 $16.6 Million - $19.3 Million
521,459 Added 32.9%
2,106,252 $74.8 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $52.7 Million - $55.9 Million
-1,585,433 Reduced 50.01%
1,584,793 $57.4 Million
Q4 2017

Jan 22, 2018

BUY
$33.26 - $35.29 $54.5 Million - $57.8 Million
1,639,165 Added 107.06%
3,170,226 $115 Million
Q3 2017

Nov 08, 2017

SELL
$31.0 - $34.15 $47.4 Million - $52.2 Million
-1,529,981 Reduced 49.98%
1,531,061 $54.7 Million
Q3 2017

Oct 12, 2017

BUY
$31.0 - $34.15 $94.9 Million - $105 Million
3,061,042
3,061,042 $0

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cornerstone Investment Partners, LLC Portfolio

Follow Cornerstone Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Investment Partners, LLC with notifications on news.